Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Treatment Uptake for HCV in VA Healthcare System

Clin Infect Dis; ePub 2018 Aug 22; Butt, et al

Between 2001-2017, nearly half of all persons in the VA healthcare system were initiated on anti-hepatitis C virus (HCV) treatment, according to a recent study. Researchers examined results from ERCHIVES to determine trends in treatment uptake and provider specialty for HCV infection in the VA healthcare system. Researchers found:

  • 108,133 persons (45.7% of diagnosed cases) were initiated on anti-HCV treatment in the VA healthcare system during the study period.
  • In 2017, non-MD clinicians accounted for 22.2% of prescriptions, infectious disease specialists for 14.9%, and gastroenterologists/hepatologists for 10.3%.
  • In the pre-direct acting antiviral (DAA) ear, they accounted for 7.2%, 26.7%, and 11.6%, respectively.

Citation:

Butt AA, Yan P, Lo Re V 3rd, Shaikh OS, Ross DB. Trends in treatment uptake and provider specialty for HCV infection in the VA healthcare system: Results from ERCHIVES. [Published online ahead of print August 22, 2018]. Clin Infect Dis. doi:10.1093/cid/ciy697.